NCT06521567 2025-11-12A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With CancerGlaxoSmithKlinePhase 1/2 Active not recruiting83 enrolled
NCT05093322 2024-06-07A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid TumorsHutchmedPhase 1/2 Completed13 enrolled 17 charts
NCT03422679 2024-01-16Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological MalignanciesCellestia Biotech AGPhase 1/2 Terminated79 enrolled 22 charts
NCT03458728 2023-12-04Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric PatientsBayerPhase 1/2 Terminated31 enrolled 17 charts
NCT02223052 2020-05-12Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCelgenePhase 1 Completed89 enrolled
NCT00154388 2016-11-18Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesNovartisPhase 2 Completed185 enrolled
NCT01169584 2016-01-21Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric PatientsSillaJen, Inc.Phase 1 Completed6 enrolled
NCT00413075 2015-07-08Study of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaValerio TherapeuticsPhase 1 Completed121 enrolled
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts